Let It TiC in Childhood Provisional Eye Tic

NCT07838428 · tracked via the Priya Life Science China tracker

Sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Phase

Not applicable

Started

2026-10-01

Last updated

2026-09-24

Condition(s) studied

Tic DisorderProvisional Tic Disorder

Investigational drug(s) / intervention(s)

Reducing Attentional Interventions Therapy TreatmentContinue with the previous treatment plan

Reducing Attentional Interventions Therapy Treatment: Reducing Attentional Interventions Therapy Treatment

Continue with the previous treatment plan: Continue with the previous treatment plan

Study summary

Clarify the effectiveness and safety of "Reduced-Attention Intervention Therapy" in treating children with Provisional tic disorder （PTD） who mainly exhibit abnormal blinking behavior

Eligibility

Sex

ALL

Min age

6 Years

Max age

14 Years

Healthy volunteers

Inclusion Criteria: 1. Age: Between 6 and 14 years old 2. the diagnosis is PTD characterized by abnormal blinking as the main manifestation 3. The legal guardian agrees and signs the informed consent form, and complies with the research protocol Exclusion Criteria: 1. Received any other behavioral intervention treatment or took related therapeutic drugs within the past 3 months. 2. The current active allergic diseases 3. There are any eye disorders that may cause confusion in the interpretation of the research results 4. Having worn contact lenses within the past 3 months 5. The researchers determined that the participants were not suitable to participate in this study due to other reasons

Primary outcome measure(s)

Score of the Yale Comprehensive Tics Severity Scale — through study completion, an average of 6 months
Three evaluation researchers who had undergone unified training and were unaware of the group assignments independently conducted blinded scoring based on the standardized protocol and the medical records provided by the same guardian of the patients. The average value was then calculated.

Trial sites (1)

Facility	City	Region	Status
Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong 510080	Guangzhou	China

More Zhongshan Ophthalmic Center, Sun Yat-sen University trials in China

A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa Starting soon

Efficacy Evaluation of 5-Fluorouracil as an Adjuvant to Endoscopic Dacryocystorhinostomy in Managing Primary Acquired Nasolacrimal Duct Obstruction With Small Lacrimal Sac: A Randomized Controlled Study Recruiting

Comparison of Two Rotational Alignment Methods for Astigmatism Correction in SMILE Surgery Starting soon

Safety and Efficacy of Blue Star MAX-5 Lenses in Myopia Control Active, not recruiting

The Proactive Ophthalmic Examination Cohort Recruiting

Other trials for the same condition

Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis Recruiting

Scalp Acupuncture Treatment for Chronic Tic Disorders in Children Enrolling by invitation

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07838428 on ClinicalTrials.gov ↗ ← All trials in China